Publication | Closed Access
Multicentric evaluation of the new HemosIL Acustar<sup>®</sup> chemiluminescence ADAMTS13 activity assay
20
Citations
11
References
2020
Year
HemosIL AcuStar<sup>®</sup> is highly sensitive to detect ADAMTS13 values below 10% and 5%. A large prospective validation study is needed to corroborate its utility in clinical practice.
| Year | Citations | |
|---|---|---|
Page 1
Page 1